What is the stability duration of diluted Venofer (iron sucrose) after refrigeration?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Stability of Diluted Venofer After Preparation

Diluted Venofer is stable for 7 days when stored at either controlled room temperature (25°C ± 2°C) or under refrigeration (4°C ± 2°C), according to FDA-approved stability data. 1

Storage Guidelines for Diluted Venofer

Syringe Preparation Stability

  • When diluted with 0.9% NaCl at concentrations ranging from 2-10 mg elemental iron per mL (or undiluted at 20 mg/mL) and stored in plastic syringes, Venofer remains physically and chemically stable for 7 days 1
  • This stability applies to both controlled room temperature storage (25°C ± 2°C) and refrigerated storage (4°C ± 2°C) 1

IV Bag Preparation Stability

  • When added to IV infusion bags (PVC or non-PVC) containing 0.9% NaCl at concentrations of 1-2 mg elemental iron per mL, Venofer is stable for 7 days at controlled room temperature (25°C ± 2°C) 1
  • Do not dilute to concentrations below 1 mg/mL 1
  • Do not mix Venofer with other medications or add to parenteral nutrition solutions 1

Critical Storage Requirements

Undiluted Product Storage

  • Store original vials at 20-25°C (68-77°F), with excursions permitted to 15-30°C (59-86°F) 1
  • Do not freeze 1
  • Contains no preservatives 1

Administration Timing

  • Venofer should be administered as soon as possible after being removed from refrigeration 2
  • Once prepared, use within the 7-day stability window to ensure optimal safety and efficacy 1

Important Safety Considerations

Pre-Administration Inspection

  • Inspect visually for particulate matter and discoloration prior to infusion 1
  • Discard if particulate matter or discoloration is observed 1

Monitoring Requirements

  • Resuscitation facilities should be available during administration, as anaphylaxis may occur with IV iron preparations 2
  • Monitor vital signs during and after infusion 3, 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Iron Sucrose Administration Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Safety of Concomitant Adderall and Venofer Use

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.